IRulya Therapeutics Inc. IRLA
39.94 USD -0.65 (-1.60%)
Regular-session close
38.76 -1.18 -2.95%
After hours · Nov 19, 5:18 PM ET
38.83 Day range 41.99
15.10 52-week range 910.00
- YTD
- -94.04%
- 1 year
- -89.65%
News
benzinga.com Cantor Fitzgerald Reiterates Overweight on IRulya Therapeutics, Maintains $70 Price Target Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates IRulya Therapeutics (NASDAQ:IRLA) with a Overweight and maintains $70 price target.
benzinga.com Citizens Maintains Market Outperform on IRulya Therapeutics, Raises Price Target to $86 Citizens analyst Jonathan Wolleben maintains IRulya Therapeutics (NASDAQ:IRLA) with a Market Outperform and raises the price target from $77 to $86.
benzinga.com IRulya Therapeutics Q3 EPS $(2.31) Beats $(19.83) Estimate IRulya Therapeutics (NASDAQ:IRLA) reported quarterly losses of $(2.31) per share which beat the analyst consensus estimate of $(19.83) by 88.35 percent. This is a 95.36 percent increase over losses…
globenewswire.com IRulya Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results Name changed from Quince Therapeutics, Inc. to IRulya Therapeutics Inc.; common stock began trading on the Nasdaq Capital Market under the ticker “IRLA” on October 12, 2026 Phase 2 data in…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Pharvaris (NASDAQ:PHVS) stock moved upwards by 19.4% to $36.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.0 billion. CalciMedica (NASDAQ:CALC)…
